These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 37140451)

  • 21. Emergence, spread and characterisation of the SARS-CoV-2 variant B.1.640 circulating in France, October 2021 to February 2022.
    Picard G; Fournier L; Maisa A; Grolhier C; Chent S; Huchet-Kervalla C; Sudour J; Pretet M; Josset L; Behillil S; Schaeffer J; ; ; ;
    Euro Surveill; 2023 Jun; 28(22):. PubMed ID: 37261732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021-February 2022.
    Sofonea MT; Roquebert B; Foulongne V; Morquin D; Verdurme L; Trombert-Paolantoni S; Roussel M; Bonetti JC; Zerah J; Haim-Boukobza S; Alizon S
    Emerg Infect Dis; 2022 Jul; 28(7):1355-1365. PubMed ID: 35642476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Booster vaccination protection against SARS-CoV-2 infections in young adults during an Omicron BA.1-predominant period: A retrospective cohort study.
    Wan J; Cazer CL; Clarkberg ME; Henderson SG; Lee SE; Meredith GR; Osman M; Shmoys DB; Frazier PI
    PLoS Med; 2023 Jan; 20(1):e1004153. PubMed ID: 36626376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suicidal ideation following self-reported COVID-19-like symptoms or serology-confirmed SARS-CoV-2 infection in France: A propensity score weighted analysis from a cohort study.
    Davisse-Paturet C; Orri M; Legleye S; Florence AM; Hazo JB; Warszawski J; Falissard B; Geoffroy MC; Melchior M; Rouquette A;
    PLoS Med; 2023 Feb; 20(2):e1004171. PubMed ID: 36787340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severity of SARS-CoV-2 Omicron variant infection in heart transplant recipients.
    Hazan F; Verdonk C; Coutance G; Ferré VM; Marot S; Melo VDD; Legeai C; Lebreton G; Para M; Varnous S; Dorent R
    J Heart Lung Transplant; 2023 May; 42(5):558-561. PubMed ID: 36822931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Values and preferences of the general population in Indonesia in relation to rapid COVID-19 antigen self-tests: A cross-sectional survey.
    Thomas C; Shilton S; Thomas C; Batheja D; Goel S; Mone Iye C; Ivanova E; Martínez-Pérez GZ
    Trop Med Int Health; 2022 May; 27(5):522-536. PubMed ID: 35332616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.
    Ng OT; Marimuthu K; Koh V; Pang J; Linn KZ; Sun J; De Wang L; Chia WN; Tiu C; Chan M; Ling LM; Vasoo S; Abdad MY; Chia PY; Lee TH; Lin RJ; Sadarangani SP; Chen MI; Said Z; Kurupatham L; Pung R; Wang LF; Cook AR; Leo YS; Lee VJ
    Lancet Infect Dis; 2021 Mar; 21(3):333-343. PubMed ID: 33152271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Head-to-head comparison of the accuracy of saliva and nasal rapid antigen SARS-CoV-2 self-testing: cross-sectional study.
    Schuit E; Venekamp RP; Veldhuijzen IK; van den Bijllaardt W; Pas SD; Stohr JJJM; Lodder EB; Hellwich M; Molenkamp R; Igloi Z; Wijers C; Vroom IH; Nagel-Imming CRS; Han WGH; Kluytmans JAJW; van den Hof S; van de Wijgert JHHM; Moons KGM
    BMC Med; 2022 Oct; 20(1):406. PubMed ID: 36280827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimising school disruption under high incidence conditions due to the Omicron variant in France, Switzerland, Italy, in January 2022.
    Colosi E; Bassignana G; Barrat A; Lina B; Vanhems P; Bielicki J; Colizza V
    Euro Surveill; 2023 Feb; 28(5):. PubMed ID: 36729116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China.
    Wang K; Guo Z; Zeng T; Sun S; Lu Y; Wang J; Li S; Luan Z; Li H; Zhang J; Wang Y; Lu Y; Zhao S
    JAMA Netw Open; 2023 Mar; 6(3):e235755. PubMed ID: 36995713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app.
    Visconti A; Murray B; Rossi N; Wolf J; Ourselin S; Spector TD; Freeman EE; Bataille V; Falchi M
    Br J Dermatol; 2022 Dec; 187(6):900-908. PubMed ID: 35869671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS).
    Maeda H; Saito N; Igarashi A; Ishida M; Terada M; Ito T; Ikeda H; Kamura H; Motohashi I; Kimura Y; Komino M; Arai H; Kuwamitsu O; Akuzawa N; Sando E; Morikawa T; Imura H; Inoue H; Hayakawa T; Teshigahara O; Ohara Y; Suzuki M; Morimoto K
    Expert Rev Vaccines; 2023; 22(1):288-298. PubMed ID: 36883371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the practicability of a finger-stick whole-blood SARS-Cov-2 self-test adapted for the general population.
    Prazuck T; Phan Van J; Sinturel F; Levray F; Elie A; Camera D; Pialoux G
    PLoS One; 2021; 16(1):e0245848. PubMed ID: 33508007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods.
    Link-Gelles R; Levy ME; Natarajan K; Reese SE; Naleway AL; Grannis SJ; Klein NP; DeSilva MB; Ong TC; Gaglani M; Hartmann E; Dickerson M; Stenehjem E; Kharbanda AB; Han J; Spark TL; Irving SA; Dixon BE; Zerbo O; McEvoy CE; Rao S; Raiyani C; Sloan-Aagard C; Patel P; Dascomb K; Uhlemann AC; Dunne MM; Fadel WF; Lewis N; Barron MA; Murthy K; Nanez J; Griggs EP; Grisel N; Annavajhala MK; Akinseye A; Valvi NR; Goddard K; Mamawala M; Arndorfer J; Yang DH; Embí PJ; Fireman B; Ball SW; Tenforde MW
    JAMA Netw Open; 2023 Mar; 6(3):e232598. PubMed ID: 36920396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case clustering, contact stratification, and transmission heterogeneity of SARS-CoV-2 Omicron BA.5 variants in Urumqi, China: An observational study.
    Lu Y; Guo Z; Zeng T; Sun S; Lu Y; Teng Z; Tian M; Wang J; Li S; Fan X; Luan Z; Wang W; Cai Y; Wang K; Zhao S
    J Glob Health; 2023 May; 13():06018. PubMed ID: 37199483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the ID NOW among symptomatic individuals during the Omicron wave.
    Stokes W; Venner AA; Buss E; Tipples G; Berenger BM
    J Med Microbiol; 2023 Feb; 72(2):. PubMed ID: 36848403
    [No Abstract]   [Full Text] [Related]  

  • 38. Self-collection and pooling of samples as resources-saving strategies for RT-PCR-based SARS-CoV-2 surveillance, the example of travelers in French Polynesia.
    Aubry M; Teiti I; Teissier A; Richard V; Mariteragi-Helle T; Chung K; Deen F; Paoaafaite T; Cao-Lormeau VM
    PLoS One; 2021; 16(9):e0256877. PubMed ID: 34473769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial.
    Love NK; Ready DR; Turner C; Verlander NQ; French CE; Martin AF; Sorensen TB; Metelmann S; Denford S; Rubin GJ; Yardley L; Amlôt R; Hopkins S; Oliver I
    Lancet Respir Med; 2022 Nov; 10(11):1074-1085. PubMed ID: 36228640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reinfections with Different SARS-CoV-2 Omicron Subvariants, France.
    Nguyen NN; Houhamdi L; Delorme L; Colson P; Gautret P
    Emerg Infect Dis; 2022 Nov; 28(11):2341-2343. PubMed ID: 36150518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.